HRT Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Buy
11,227
+5,149
+85% +$900K 0.01% 1584
2025
Q4
$1.03M Buy
+6,078
New +$932K ﹤0.01% 1694
2025
Q2
Sell
-118,147
Closed -$14.7M 3106
2025
Q1
$14.7M Buy
118,147
+107,294
+989% +$14M 0.09% 166
2024
Q4
$1.34M Sell
10,853
-27,509
-72% -$3.24M 0.01% 928
2024
Q3
$4.27M Sell
38,362
-51,261
-57% -$5.62M 0.02% 534
2024
Q2
$9.56M Buy
+89,623
New +$9.85M 0.05% 258
2024
Q1
Sell
-6,062
Closed -$745K 2685
2023
Q4
$745K Sell
6,062
-27,561
-82% -$3.44M 0.01% 1141
2023
Q3
$4.35M Buy
+33,623
New +$4.48M 0.04% 341
2021
Q4
Sell
-11,990
Closed -$1.56M 3618
2021
Q3
$1.56M Sell
11,990
-21,701
-64% -$3.28M 0.01% 896
2021
Q2
$5.98M Buy
33,691
+27,093
+411% +$4.69M 0.05% 267
2021
Q1
$1.08M Buy
+6,598
New +$1.09M 0.01% 1044
2020
Q3
Sell
-17,470
Closed -$1.93M 2122
2020
Q2
$1.93M Buy
+17,470
New +$1.93M 0.06% 349
2019
Q4
Sell
-1,951
Closed -$250K 1397
2019
Q3
$250K Sell
1,951
-2,385
-55% -$320K 0.01% 1036
2019
Q2
$618K Buy
+4,336
New +$583K 0.04% 369

Other funds holding JAZZ

HRT Financial's JAZZ Position: Q1 2026 in Review

HRT Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 85% in Q1 2026, buying an estimated $900K and bringing the position to 11,227 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #1584.

HRT Financial first reported a position in JAZZ in Q2 2019 and has held it in 14 quarters since. The position peaked at $14.7M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • HRT Financial held 11,227 shares of Jazz Pharmaceuticals worth $2.12M as of Q1 2026.
  • HRT Financial bought 5,149 Jazz Pharmaceuticals shares in Q1 2026, an estimated $900K.
  • Jazz Pharmaceuticals made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1584 holding.
  • HRT Financial first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 14 quarters since.
  • HRT Financial's Jazz Pharmaceuticals position peaked at $14.7M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.